Rich Welsh, a 28 year-old insurance agent from Klemme, Iowa who suffered a spinal cord injury after an automobile accident in 1999, is now on the road to recovery after stem cell therapy in Cologne, Germany.
Cologne, Germany (PRWEB) February 7, 2008 — Rich Welsh, a 28 year-old insurance agent from Klemme, Iowa who suffered a spinal cord injury after an automobile accident in 1999, is now on the road to recovery after stem cell therapy in Cologne, Germany.
Mr. Welsh became a C-5 quadriplegic after his unfortunate accident. Since then, he has received adult stem cell therapy twice; the latest time in mid-2007. Following these treatments, Mr. Welsh can now feel hot and cold sensations in his stomach and his muscle spasms have decreased significantly. He has also regained the ability to sweat. However, his most notable gain has occurred since his second treatment – return of sexual function. “Since that treatment I have started regaining my sexual function. No more blue pill,” joked Welsh. When asked what advice he would give to those considering this treatment, Mr. Welsh replied, “If you happen to come across the chance of having autologous stem cell therapy that may improve your quality of life – do not let it pass you by.”
The spinal cord injury treatment at XCell-Center employs (autologous) stem cells that come from the patient’s own bone marrow. After the stem cells are separated from the bone marrow, they are implanted into the spinal canal under local anesthesia. This procedure is very safe and takes about 30 minutes.
About the XCell-Center
The XCell-Center is the first privately-owned center in Europe to specialize in regenerative medicine using autologous bone marrow adult stem cell therapy. Newly completed in early 2007, the XCell-Center is a fully licensed clinic featuring the latest medical equipment and technology. Its specialized medical team of German physicians includes: neurologists, endocrinologists, cardiologists, radiologists, hematologists, and pharmacologists. The XCell-Center works in accordance with German law and European guidelines.
The XCell-Center currently treats Diabetes and its complications (Erectile Dysfunction and Peripheral Artery Disease), Stroke, Spinal Cord Injuries, Ischemic Heart Disease and degenerative diseases such as Multiple Sclerosis, Parkinson’s and Alzheimer’s.
The XCell-Center has submitted its SCIDIM I and II trials to its investigational review board. In these trials, diabetes (type I and II) patients are being treated with their own stem cells and compared with a control group receiving traditional therapy. The findings will be presented at different international scientific meetings. Also later this year, another clinical trial for stroke patients will commence. These trials are only open to German residents.
For more information on Stem Cell Therapy:
XCell-Center Website: http://www.xcell-center.com
XCell-Center GmbH
at the Institute for Regenerative Medicine
Custodisstrasse 3-17
Cologne, Germany 50679
Phone: 1-866-680-8202 (USA Toll-Free)
(+49) 0221-802-5095 (Germany)
Fax: (+49) 0221-2921-2550 (Germany)
1-713-583-9322 (USA)
